We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Nexfin Pulse Contour Analysis and Cardiac Magnetic Resonance Imaging for the Measurement of Cardiac Output

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01639313
Recruitment Status : Completed
First Posted : July 12, 2012
Last Update Posted : July 12, 2012
Sponsor:
Information provided by (Responsible Party):
Joachim Saur, University Hospital Mannheim

Brief Summary:
A growing interest in monitoring cardiac output (CO) non-invasively has emerged, however its determination has been difficult using the standard approaches. The aim of the study is to evaluate the accuracy and precision of pulse contour analysis (PCA) as compared to cardiac magnetic resonance imaging (CMR).

Condition or disease
Cardiac Diseases

Study Type : Observational
Actual Enrollment : 39 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Is Arterial Pulse Contour Analysis Using Nexfin a New Option in the Non-invasive Measurement of Cardiac Output? - A Pilot Study
Study Start Date : June 2011
Primary Completion Date : November 2011
Study Completion Date : November 2011




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Hemodynamically stable patients undergoing CMR
Criteria

Inclusion Criteria:

  • indication for CMR

Exclusion Criteria:

  • contraindication for CMR
  • claustrophobia
  • no consent obtained

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01639313


Locations
Germany
Universitätsmedizin Mannheim
Mannheim, Germany, 68259
Sponsors and Collaborators
Universitätsmedizin Mannheim

Responsible Party: Joachim Saur, Principal Investigator, University Hospital Mannheim
ClinicalTrials.gov Identifier: NCT01639313     History of Changes
Other Study ID Numbers: PCA_CMR_MA
First Posted: July 12, 2012    Key Record Dates
Last Update Posted: July 12, 2012
Last Verified: July 2012

Additional relevant MeSH terms:
Heart Diseases
Cardiovascular Diseases